Proximal Ventures raises debut fund to back startups bringing AI to drug development | TechCrunch
While established venture firms continue to attract capital, first-time fund managers are facing one of the toughest fundraising environments in years. But that didn’t stop Sahir Raoof, a former SignalFire investor and executive at two healthcare startups, from raising $27.5 million for his first solo VC fund.
Raoof’s firm, Proximal Ventures, is betting that AI can transform the tools, infrastructure, and services that support drug development.
Linha do tempo
-
Proximal Ventures raises debut fund to back startups bringing AI to drug development | TechCrunch
ler a análise desta fonte ocultar
While established venture firms continue to attract capital, first-time fund managers are facing one of the toughest fundraising environments in years. But that didn’t stop Sahir Raoof, a former SignalFire investor and executive at two healthcare startups, from raising $27.5 million for his first solo VC fund.
Raoof’s firm, Proximal Ventures, is betting that AI can transform the tools, infrastructure, and services that support drug development.